Human Immmunodeficiency Virus 1–associated Minor Motor Disorders: Perfusion-weighted MR Imaging and1H MR Spectroscopy
Authors:
- Frank WenserskiFWFrank Wenserski
- Hans-Juergen von GiesenHGHans-Juergen von Giesen
- Hans-Joerg WittsackHWHans-Joerg Wittsack
- Albrecht AulichAAAlbrecht Aulich
- Gabriele ArendtGAGabriele Arendt
- 1 July 2003
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 228 (1) , 185-192
Abstract
To investigate whether advanced magnetic resonance (MR) imaging techniques such as diffusion-weighted (DW) and perfusion-weighted (PW) MR imaging and hydrogen 1 (1H) MR spectroscopy can depict functional and pathophysiologic mechanisms in patients who have minor motor deficits (MMDs) associated with human immunodeficiency virus 1 (HIV-1). Thirty-two patients with results seropositive for HIV-1 and different degrees of HIV-1-related MMD underwent conventional brain MR imaging, as well as DW and PW MR imaging and 1H MR spectroscopy of the basal ganglia. PW MR imaging data were computed pixel by pixel for creation of time-to-peak, relative regional cerebral blood volume, and bolus amplitude parameter maps. In addition, quantitative regional cerebral blood flow (rCBF) maps were calculated with respect to the arterial input function by using the singular value decomposition algorithm. For 1H MR spectroscopy, a stimulated echo acquisition mode 20, or STEAM 20, sequence was used. Spectra were fit for determination of the signal intensities of the different metabolites. According to psychomotor testing results, patients were divided into three groups: group 1, 10 patients with normal motor function; group 2, eight patients with psychomotor slowing for the first time; and group 3, 14 patients who had had sustained pathologic psychomotor slowing for at least 6 months before the MR imaging examination. No patients had an abnormality at either conventional or DW MR imaging. PW MR imaging depicted significantly elevated rCBF in group 2 patients (P =.039, analysis of variance [ANOVA]) and significantly elevated myo-inositol-to-creatine ratio levels in group 3 patients (P =.020, ANOVA). Quantitative PW MR imaging and 1H MR spectroscopy can depict pathologic changes in patients who have HIV-1-related MMD but normal clinical examination and conventional MR imaging findings.Keywords
This publication has 47 references indexed in Scilit:
- Therapeutic effects of nucleoside analogues on psychomotor slowing in HIV infectionAIDS, 2001
- Potential Time Course of Human Immunodeficiency Virus Type 1–Associated Minor Motor DeficitsArchives of Neurology, 2000
- HIV dementia: the role of the basal ganglia and dopaminergic systemsJournal of Psychopharmacology, 2000
- HAART Is Neuroprophylactic in HIV-1 InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- HIV Dementia and the Basal GangliaIntervirology, 1997
- HIV Dementia Scale: A Rapid Screening TestJAIDS Journal of Acquired Immune Deficiency Syndromes, 1995
- Motor analysis predicts progression in HIV-associated brain diseaseJournal of the Neurological Sciences, 1994
- HIV-specific changes in the motor performance of HIV-positive intravenous drug abusersJournal of Neurology, 1994
- Improvement of motor performance of HIV‐positive patients under AZT therapyNeurology, 1992
- Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infectionNeurology, 1991